West Pharmaceutical Services Inc banner

West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 306.16 USD -1.14% Market Closed
Market Cap: $22.1B

EV/OCF

28.5
Current
7%
Cheaper
vs 3-y average of 30.8

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
28.5
=
Enterprise Value
$17.6B
/
Operating Cash Flow
$754.8m

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
28.5
=
Enterprise Value
$17.6B
/
Operating Cash Flow
$754.8m

Valuation Scenarios

West Pharmaceutical Services Inc is trading below its 3-year average

If EV/OCF returns to its 3-Year Average (30.8), the stock would be worth $330.13 (8% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-42%
Maximum Upside
+15%
Average Downside
5%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 28.5 $306.16
0%
3-Year Average 30.8 $330.13
+8%
5-Year Average 32.9 $352.7
+15%
Industry Average 27.7 $297.72
-3%
Country Average 16.7 $179.05
-42%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
US
West Pharmaceutical Services Inc
NYSE:WST
22B USD 28.5 44.7
US
PerkinElmer Inc
LSE:0KHE
1T USD 1 774.1 4 280.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
176.7B USD 25.7 26.4
US
Danaher Corp
NYSE:DHR
125.4B USD 21.3 34
KR
Samsung Biologics Co Ltd
KRX:207940
82.3T KRW 36.2 46.1
CN
WuXi AppTec Co Ltd
SSE:603259
298.9B CNY 15.4 15.6
CH
Lonza Group AG
SIX:LONN
34.3B CHF 31 -118.2
US
Agilent Technologies Inc
NYSE:A
32.7B USD 24.5 25.3
US
Waters Corp
NYSE:WAT
30.4B USD 47.1 47.3
US
IQVIA Holdings Inc
NYSE:IQV
27.5B USD 14.8 20.3
US
Mettler-Toledo International Inc
NYSE:MTD
26.1B USD 29.4 30

Market Distribution

Higher than 79% of companies in the United States of America
Percentile
79th
Based on 9 518 companies
79th percentile
28.5
Low
0 — 11.7
Typical Range
11.7 — 23.6
High
23.6 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 11.7
Median 16.7
70th Percentile 23.6
Max 3 178 983.5

West Pharmaceutical Services Inc
Glance View

Nestled in the heart of the pharmaceutical and healthcare industry is West Pharmaceutical Services Inc., a company that has woven itself into the fabric of drug delivery systems since its founding in 1923. This company, headquartered in Exton, Pennsylvania, operates with the precision of a Swiss watch, designing and manufacturing an array of cutting-edge containment and delivery solutions for injectable medicines. West's expertise is reflected in the products it develops—ranging from stoppers and seals for vials to advanced syringe and device technologies. Its robust research and development pipeline underscores a commitment to innovation, ensuring that new advances in drug delivery provide critical safety and efficacy for patients and healthcare professionals alike. West Pharmaceutical's business model revolves around partnering closely with pharmaceutical and biotechnology companies worldwide. This symbiotic relationship secures West's place at the forefront of global healthcare evolution. While the client companies focus on the complex process of drug formulation and therapeutic efficacy, West ensures that these drugs are delivered effectively and safely through its meticulously engineered components and systems. As a result, the company garners a revenue stream from a robust portfolio of products and services that cater to the long-term needs of its clients, helping them efficiently navigate the stringent regulatory environment. Through these partnerships and their resultant dividends, West Pharmaceutical Services continues to embed its name into the essential infrastructure of global health care.

WST Intrinsic Value
218.37 USD
Overvaluation 29%
Intrinsic Value
Price $306.16
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett